Mylan Laboratories, Inc. (NASDAQ:MYL)

CAPS Rating: 4 out of 5

The Company develops, licenses, manufactures, markets and distributes generic, brand and branded generic pharmaceutical products and active pharmaceutical ingredients.

Recs

0
Player Avatar stovkey1highdiv (< 20) Submitted: 4/14/2011 10:04:08 PM : Outperform Start Price: $23.32 MYL Score: -7.47

key03, no dividend

Featured Broker Partners


Advertisement